Atlas Trials

Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies

Clinical trial NCT00113828 · TERMINATED

Trial details

NCT number
NCT00113828
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
LymphomaLeukemiaMultiple MyelomaMyelodysplastic Syndrome
Start date
2004-12-01
Primary completion
2007-03-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.